MVM Partners
3 rounds tracked since 2 September 2025.
- Rounds
- 3
- Led
- 3
- Capital in these rounds
- $191M
Sectors
Countries
Rounds
- Neurent MedicalLeadNEUROMARK device treating chronic rhinitis $74.4MSeries C · 11 Feb
- Avanzanite BioscienceLeadCommercialises orphan medicines for rare diseases across 32 European countries $37.1MSeries A · 17 Nov
- ProVerumLeadMaker of the ProVee System, a minimally invasive stent for enlarged prostate $80MSeries B · 2 Sept
No round matches these filters.